Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8ZLV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,521
Award facts
- Contract value 100% obligated
- $35,520.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,520.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, representing routine pharmaceutical procurement for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical vendor for federal medical supply chains, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capacity to fulfill federal procurement requirements through open competition and deliver varied pharmaceutical products at multiple price points positions it as a critical vendor for the department's ongoing medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F8ZLV?
SPE2DR26F8ZLV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F8ZLV worth?
The government has obligated $35,521 on SPE2DR26F8ZLV.
Is contract SPE2DR26F8ZLV an order under another contract?
Yes. SPE2DR26F8ZLV is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZLV competed?
The extent of competition for SPE2DR26F8ZLV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award